Clinical Trial Update: Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia [NA]

View source ↗

Summary

This clinical trial update reports compassionate-use treatment with Campath-1H (alemtuzumab) for patients with refractory prolymphocytic leukemia or chronic lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia

Drugs mentioned

• Campath-1H (alemtuzumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia | NA | Status: COMPLETED